Alvotech (ALVO) Retained Earnings (2020 - 2026)
Alvotech (ALVO) posted Retained Earnings of $16.2 million for Q1 2026, up 5.66% on a QoQ basis from $15.3 million in Q4 2025, and down 6.81% year-over-year from $17.4 million in Q1 2025.
Alvotech (ALVO) Retained Earnings (2020 - 2026) Analysis & Trends
Alvotech's Retained Earnings history runs 7 years deep, the most recent figure standing at $16.2 million for Q1 2026.
- Quarterly Retained Earnings fell 6.81% year-over-year to $16.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.2 million (down 6.81% YoY) and the FY2025 annual result came in at $15.3 million, down 11.24% from the prior year.
- Retained Earnings was $16.2 million for Q1 2026 at Alvotech, up from $15.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $42.9 million in Q4 2023 and bottomed at -$1.3 billion in Q2 2022.
- A 5-year average of -$70.4 million and a median of $17.3 million in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings soared 102.89% — and 2024, when it plunged 59.75%.
- Alvotech's Retained Earnings stood at $30.6 million in 2022, then soared by 40.31% to $42.9 million in 2023, then slumped by 59.75% to $17.3 million in 2024, then fell by 11.24% to $15.3 million in 2025, then gained by 5.66% to $16.2 million in 2026.
- Business Quant data shows ALVO's Retained Earnings at $16.2 million in Q1 2026, $15.3 million in Q4 2025, and $17.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 16.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.20 Mn |
| Dec 31, 2025 | 15.33 Mn |
| Sep 30, 2025 | 17.27 Mn |
| Jun 30, 2025 | 15.63 Mn |
| Mar 31, 2025 | 17.38 Mn |
| Dec 31, 2024 | 17.27 Mn |
| Sep 30, 2024 | 16.61 Mn |
| Jun 30, 2024 | 35.63 Mn |
| Mar 31, 2024 | 38.88 Mn |
| Dec 31, 2023 | 42.91 Mn |
| Jun 30, 2023 | 38.31 Mn |
| Mar 31, 2023 | 37.77 Mn |
| Dec 31, 2022 | 30.58 Mn |
| Jun 30, 2022 | -1.33 Bn |
| Dec 31, 2021 | -1.14 Bn |
| Dec 31, 2020 | -1.04 Bn |